GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Standard Chemical & Pharmaceutical Co Ltd (TPE:1720) » Definitions » Inventory-to-Revenue

Standard Chemical & Pharmaceutical Co (TPE:1720) Inventory-to-Revenue : 0.99 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Standard Chemical & Pharmaceutical Co Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Standard Chemical & Pharmaceutical Co's Average Total Inventories for the quarter that ended in Mar. 2024 was NT$1,597 Mil. Standard Chemical & Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was NT$1,614 Mil. Standard Chemical & Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.99.

Standard Chemical & Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 increased from Sep. 2023 (0.93) to Sep. 2023 (0.99)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Standard Chemical & Pharmaceutical Co's Days Inventory for the three months ended in Mar. 2024 was 162.25.

Inventory Turnover measures how fast the company turns over its inventory within a year. Standard Chemical & Pharmaceutical Co's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.56.


Standard Chemical & Pharmaceutical Co Inventory-to-Revenue Historical Data

The historical data trend for Standard Chemical & Pharmaceutical Co's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard Chemical & Pharmaceutical Co Inventory-to-Revenue Chart

Standard Chemical & Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 0.22 0.21 0.23 0.22

Standard Chemical & Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.96 1.00 0.93 0.99

Competitive Comparison of Standard Chemical & Pharmaceutical Co's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Standard Chemical & Pharmaceutical Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Standard Chemical & Pharmaceutical Co's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Standard Chemical & Pharmaceutical Co's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Standard Chemical & Pharmaceutical Co's Inventory-to-Revenue falls into.



Standard Chemical & Pharmaceutical Co Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Standard Chemical & Pharmaceutical Co's Inventory-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Inventory-to-Revenue (A: Dec. 2022 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2021 ) + Total Inventories (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )
=( (1217.528 + 1386.483) / 2 ) / 5851.368
=1302.0055 / 5851.368
=0.22

Standard Chemical & Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue (Q: Mar. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Sep. 2023 ) + Total Inventories (Q: Mar. 2024 )) / count ) / Revenue (Q: Mar. 2024 )
=( (1520.828 + 1673.348) / 2 ) / 1613.535
=1597.088 / 1613.535
=0.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Standard Chemical & Pharmaceutical Co  (TPE:1720) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Standard Chemical & Pharmaceutical Co's Days Inventory for the three months ended in Mar. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2024 )/Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=1597.088/898.191*365 / 4
=162.25

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Standard Chemical & Pharmaceutical Co's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2024 ) / Average Total Inventories (Q: Mar. 2024 )
=898.191 / 1597.088
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Standard Chemical & Pharmaceutical Co Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Standard Chemical & Pharmaceutical Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Standard Chemical & Pharmaceutical Co (TPE:1720) Business Description

Traded in Other Exchanges
N/A
Address
No. 154, Kaiyuan Road, Xinying District, Tainan, TWN, 73055
Standard Chemical & Pharmaceutical Co Ltd is a pharmaceutical company. Along with its subsidiaries, the firm is engaged in the pharmaceutical development, manufacturing, and sales of Active Pharmaceuticals Ingredients (API), health supplements, medical equipment, neoangelac plus milk powder, and adult supplements. It offers pharmaceutical products in healthcare segments including the circulatory system, digestive system, metabolism, anti-microbial, membrane drugs, and respiratory system. The company generates a majority of its revenue from Taiwan.

Standard Chemical & Pharmaceutical Co (TPE:1720) Headlines

No Headlines